Evidence map›Paper›PMID 41233810›Full record

ArticleBMC infectious diseases2025

Clinical epidemiological characteristics and treatment outcomes of Brucella spondylitis in Ningxia, China: a 12‑year single‑center retrospective study.

Kun Wang, Zhangui Gu, Qiang Liu, Long Ma, Minyu Li, Hanhua Guo, Jianqiang Gao, Zongqiang Yang, Jiandang Shi

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kun Wang *Department of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Zhangui Gu *Department of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Qiang Liu *Department of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Long MaDepartment of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Minyu LiDepartment of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Hanhua GuoDepartment of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Jianqiang GaoDepartment of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Zongqiang YangDepartment of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China. yzq_nyzy@126.com.
Jiandang ShiDepartment of Orthopedic, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China. shi_jiandang@nxmu.edu.cn.

Funding

the Health and Medical Research Project of Ningxia Hui Autonomous Region 2025-NWZC-B001the Key Research and Development Project of Ningxia Hui Autonomous Region 2022BEG03090the Open Project of the State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia SKL-HDCA-2024-NX2
6 · The paper itself

Abstract

backgroundEpidemiological and clinical analyses of Brucellar spondylitis (BS) are crucial for public health authorities to enhance disease surveillance and optimize case management strategies. However, clinical epidemiological research on BS remains limited. This study analyzed the clinical and epidemiological characteristics of hospitalized BS patients at a hospital in Ningxia, aiming to provide evidence to support region-specific strategies for BS prevention and control.

methodsWe retrospectively collected demographic profiles, epidemiological characteristics, clinical presentations, laboratory/imaging findings, therapeutic regimens, and prognostic outcomes of BS inpatients admitted to the orthopedic department of a hospital in Ningxia from January 2012 to December 2023.

resultsA total of 821 patients with BS were included, consisting of 564 males (68.7%; 564/821) and 257 females (31.3%; 257/821), with a median age of 55 years (range: 18-88 years). Among all patients (n = 821), 466 (56.76%) were agricultural or pastoral workers, and 578 (70.4%) had a documented history of contact with cattle or sheep. Low back pain was the most common presenting symptom, reported in 779 cases (94.88%; 779/821). The combined positive rate of the Rose Bengal Plate Test (RBPT) and the Standard Agglutination Test (SAT) in serological testing was 90.99% (747/821). Blood cultures were performed in 618 patients, of whom 217 (35.11%; 217/618) yielded positive results. Imaging examinations revealed that the lumbar spine was the most frequently involved region (59.81%; 491/821), with the L4-L5 segment being the most commonly affected (20.83%; 171/821). Single-segment involvement was observed in 668 patients (81.37%; 668/821), single-vertebra involvement in 44 patients (5.36%; 44/821), and multi-segment or trans-segment involvement in 109 patients (13.28%; 109/821). Of the 465 patients who underwent surgical treatment, the most common procedure was posterior fixation combined with lesion debridement, performed in 215 cases (46.24%; 215/465). Among the 754 patients who completed follow-up, the most frequently used antibiotic regimen was doxycycline plus rifampicin (60.05%; 493/754). Relapse occurred in 26 patients during follow-up (3.45%; 26/754).

conclusionBrucellar spondylitis in Ningxia exhibits a temporal pattern aligned with regional brucellosis trends. Strengthening imaging-based diagnosis, clinical evaluation, and targeted follow-up of high-risk populations may help reduce recurrence and improve disease control. CLINICAL TRIAL: Not applicable.

Indexed as

BrucellosisSpondylitisAdolescentAdultAgedAged, 80 and overAnimalsAnti-Bacterial AgentsBrucellaChinaFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsBrucellar spondylitisClinical epidemiologyClinical featuresManagementTreatment outcomes

Identifiers

PMID41233810
PMCPMC12613742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.